$1.29
Value $7.9M
CDLX and MU stock compared: price, dividend, valuation and results, from SEC filings.
$1.29
Value $7.9M
$719.02
Value $814B
Cardlytics (CDLX) has a market value of $7.9M and Micron Technology (MU) $814B. Over the last year, with dividends, CDLX moved -90.7% and MU +191.6%. Dividend yield: CDLX none, MU 0.08%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CDLX$7.9M
MU$814B
MU is 103,359 times CDLX
Revenue, 12 months
CDLX$176M
MU$133B
MU is 757 times CDLX
Net income, 12 months
CDLX-$37M
MU$85.0B
Operating margin
CDLX-19.2%
MU74.6%
93.8 points apart
ROIC
CDLX-11.8%
MU89.7%
101.4 points apart
P/E
CDLX–
MU9.6
Dividend yield
CDLX0.0%
MU0.1%
0.1 points apart
5-year return
CDLX-99.9%
MU+859.3%
959.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CDLX-99.9%
MU+859.3%
| Period | CDLXWith dividends | MUWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -90.7%Price -90.7% | +191.6%Price +191.3% |
| 3 years since November 16, 2023 | -98.2%-73.7% a yearPrice -98.2% | +847.0%+111.6% a yearPrice +837.8% |
| 5 years since November 15, 2021 | -99.9%-72.9% a yearPrice -99.9% | +859.3%+57.2% a yearPrice +836.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CDLXCardlyticsMUMicron Technology
| Price | $1.29 | $719.02 |
|---|---|---|
| Market value | $7.9M | $814B |
| Enterprise value (EV) | $173M | $775B |
| P/E | – | 9.6 |
| P/E, 5-year median | – | 12.9 |
| P/B | – | 5.9 |
| EV/EBIT | – | 7.8 |
| Free cash flow yield | – | 7.2% |
| Revenue, 12 months | $176M | $133B |
|---|---|---|
| Net income, 12 months | -$37M | $85.0B |
| Free cash flow, 12 months | -$7.2M | $59.0B |
| Earnings per share, 12 months | -$19.50 | $74.33 |
| Revenue growth, year on year | -16.2% | 256.3% |
| Revenue growth a year, past | +4.5%over 5 years | +36.9%over 5 years |
| EPS growth a year, past | – | +70.6%over 5 years |
| Gross margin | – | 80.7% |
|---|---|---|
| Operating margin | -19.2% | 74.6% |
| Net margin | -20.8% | 63.8% |
| ROIC | -11.8% | 89.7% |
| ROE | – | 100.1% |
| Cash | $30M | $43.4B |
|---|---|---|
| Total debt | $200M | $5.2B |
| Net debt / EBITDA | – | -0.4 |
| Interest cover | – | 937.2× |
| Dividend yield | – | 0.1% |
|---|---|---|
| Dividend per share, 12 months | – | $0.57 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 0.1% |
| Shareholder yield | – | 0.2% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Micron Technology ($814B) is about 103,359.3 times Cardlytics ($7.9M), at today's prices.
Since November 15, 2021, CDLX's price moved -99.9% and MU's +836.5%. With dividends: CDLX -99.9% (-72.9% a year), MU +859.3% (+57.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Cardlytics and 0.08% for Micron Technology. Over the last twelve months they paid – and $0.57 per share.
Over the last twelve months, the net margin was -20.8% for Cardlytics and 63.8% for Micron Technology, and the operating margin -19.2% and 74.6%. Revenue was $176M and $133B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.